Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in DARE — Dare Bioscience, Inc.

CIK 1214717 BOSTON, MA
Back to DARE Full portfolio

Position in DARE

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$295,595
-$28,071 QoQ
Shares Held
140,093
-21.2% QoQ
Ownership
0.916%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 27 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names. DARE ranks #386 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in DARE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $295,595 140,093
2026-03-31 $323,666 177,839
2025-12-31 $229,004 118,655
2025-09-30 $259,083 123,373
2025-06-30 $228,136 95,455
2025-03-31 $277,165 95,905
2024-12-31 $289,076 92,653
2024-09-30 $288,554 89,060
2024-06-30 $338,203 1,006,561
2024-03-31 $484,760 989,308
2023-12-31 $300,075 971,119
2023-09-30 $377,906 817,979
2023-06-30 $743,775 817,336
2023-03-31 $850,029 817,336
2022-12-31 $678,388 817,336
2022-09-30 $819,222 819,223
2022-06-30 $880,104 715,532
2022-03-31 $1,040,814 698,533
2021-12-31 $965,235 482,618
2021-09-30 $946,368 566,688
2021-06-30 $586,501 310,318
2021-03-31 $438,120 259,243
2020-12-31 $282,796 211,042
2020-09-30 $88,130 88,219
2020-06-30 $87,248 88,219
2020-03-31 $74,986 88,219